腹主动脉腔内修复术后晚期开放转换的指征与结局
该回顾性单中心研究分析了2004至2020年间443例连续腹主动脉腔内修复(EVAR)术后需开放转换的患者,共31例(含3例外院转诊),中位年龄75岁,94%为男性。开放转换指征主要为移植物移位或疾病进展伴内漏Ia和/或Ib型(52%)及II型内漏致瘤囊扩张(26%)。30天死亡率为3%,中位随访47.5个月,1、3、5年估算累积生存率分别为97%、89%、84%。
要点
- EVAR术后晚期开放转换指征以移植物移位或疾病进展伴内漏Ia和/或Ib型(52%)及II型内漏致瘤囊扩张(26%)为主。
- 31例开放转换患者中,30天死亡率为3%,中位随访47.5个月,1、3、5年估算累积生存率分别为97%、89%、84%。
- 所有患者均符合所植入内移植物的器械特定使用说明。
核心结论
- 晚期开放转换仍是有价值的治疗选择,在择期和急诊情况下均可安全施行,早期死亡率低。
- EVAR术后终身监测并在必要时及时干预对确保最佳结局和避免紧急转换至关重要。
研究设计与样本
- 回顾性单中心研究,回顾2004至2020年所有接受EVAR的患者,识别EVAR术后超过1个月的开放手术转换,排除移植物感染导致的转换。
- 2004至2020年间共施行443例连续EVAR,28例需开放手术转换,另有3例来自其他医院转诊(N=31)。
- 中位年龄75岁(范围58-93),94%为男性;转换在中位时间55个月(范围16-209)后进行;20例择期转换,11例急诊转换。
- 主要终点为30天死亡率;次要终点为再干预和随访死亡率。
主要发现
- 开放转换指征为移植物移位或疾病进展伴内漏Ia和/或Ib型,占52%(16/31);II型内漏致瘤囊扩张占26%(8/31)。
- 31例患者中17例(55%)至少接受过一次既往血管腔内再干预;所有患者均符合所植入内移植物的器械特定使用说明。
- 院内干预率为16%(5/31);30天死亡率为3%(1/31),该患者因破裂后完全替换内移植物后多器官衰竭死亡。
- 随访期间5例(16%)死亡;中位随访47.5个月(范围24-203),1、3、5年估算累积生存率分别为97%、89%、84%。
临床怎么用
- 作者认为晚期开放转换仍是有价值的治疗选择,在择期和急诊情况下均可安全施行,早期死亡率低。
- 作者认为EVAR术后终身监测和必要时及时干预对确保最佳结局和预防紧急转换的需要至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular aortic repair (EVAR) has become the standard of care for patients with infrarenal aortic aneurysms over the last 2 decades. Endograft technology and treatment of complications like endoleaks, graft migration, or graft occlusion developed over time. However, sometimes open surgical conversion maybe required. Our aim was to analyze the indications, the technical aspects and outcomes in patients who underwent open conversion after EVAR with different types and generations of endografts. METHODS: This retrospective single-center study reviewed all patients who underwent EVAR from 2004 to 2020. Open surgical conversions >1 month post EVAR were identified. Conversions for graft infection were excluded. Indications for conversion and operative technique were analyzed. Primary endpoint of the study was 30-day mortality. Secondary endpoints were re-interventions and follow-up mortality. RESULTS: During 2004 and 2020, 443 consecutive EVARs were performed, and 28 patients required open surgical conversion, with an additional 3 referred from other hospitals (N = 31). The median age was 75 (range 58-93); 94% were male. Conversion was performed after a median time of 55 months (range 16-209). Twenty patients underwent elective and 11 emergency conversion. Indications for open conversion were graft migration, respectively, disease progression with endoleak type Ia and/or Ib in 52% (16/31) and sac expansion due to endoleak type II in 26% (8/31). Of the 31 patients, 17 (55%) had at least one previous endovascular re-intervention. All patients met the device-specific instructions for use for each implanted endograft. In-hospital intervention rate was 16% (5/31). Thirty-day mortality rate was 3% (1/31) with one patient died due to multiorgan failure after rupture with complete endograft replacement. Five patients (16%) died during follow-up. Mid-term follow-up was 47.5 months (range 24-203) with estimated cumulative survival rates of 97%, 89%, and 84%, at 1, 3, and 5 years, respectively. CONCLUSIONS: Late open conversion remains a valuable treatment option and can be performed safely in elective and emergency setting with a low early mortality. Lifelong surveillance and prompt intervention when necessary are essential in ensuring optimal outcomes after EVAR and preventing the need for emergent conversions.
引用
- Becker D, Riggi M, Wyss TR, et al. Indication and Outcome of Late Open Conversion after Abdominal Endovascular Aortic Repair. Ann Vasc Surg. 2024. PMID: 38810725. doi:10.1016/j.avsg.2024.02.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。